Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3065 |
|
| Actual shortage: | 231 (8%) | |
| Anticipated shortage: | 16 (1%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2809 (92%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
30 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-SERTRALINE | 100MG | CAPSULE | Actual shortage | 2024-05-24 | 2024-05-24 | 228786 |
| APO-ATOMOXETINE | 100MG | CAPSULE | Actual shortage | 2024-05-24 | 2024-05-24 | 228792 |
| APO-RIVAROXABAN | 15MG | TABLET | Actual shortage | 2024-05-24 | 2024-05-24 | 228801 |
| APO-HYDRALAZINE | 25MG | TABLET TABLET | Actual shortage | 2024-05-24 | 2024-05-24 | 228804 |
| APO-CLOPIDOGREL | 300MG | TABLET | Actual shortage | 2024-05-24 | 2024-05-24 | 228813 |
| APO-ANASTROZOLE | 1MG | TABLET | Anticipated shortage | 2024-04-12 | 2024-05-30 | 225101 |
| APO-ANASTROZOLE | 1MG | TABLET | Anticipated shortage | 2024-05-30 | 2024-05-30 | 229161 |
| APO-ATOMOXETINE | 25MG | CAPSULE | Anticipated shortage | 2024-05-30 | 2024-05-30 | 229164 |
| APO-ATOMOXETINE | 40MG | CAPSULE | Anticipated shortage | 2024-05-30 | 2024-05-30 | 229167 |
| APO-AMLODIPINE-ATORVASTATIN | 80MG 10MG | TABLET | Actual shortage | 2024-02-16 | 2024-05-30 | 219843 |
| APO-CEFEPIME | 1G | POWDER FOR SOLUTION | Actual shortage | 2024-05-03 | 2024-05-30 | 227082 |
| APO-CEFEPIME | 2G | POWDER FOR SOLUTION | Actual shortage | 2024-05-24 | 2024-05-30 | 228807 |
| APO-TERBINAFINE | 250MG | TABLET | Actual shortage | 2024-05-03 | 2024-05-30 | 227065 |
| APO-AMIODARONE TABLETS | 200MG | TABLET | Actual shortage | 2024-05-24 | 2024-05-30 | 228816 |
| APO-SALBUTAMOL HFA | 100MCG | METERED-DOSE AEROSOL | Resolved | 2023-07-13 | 2024-05-31 | 198539 |
| APO-GLICLAZIDE MR | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-26 | 2024-05-31 | 217481 |
| APO-SITAGLIPTIN MALATE | 25MG | TABLET | Resolved | 2024-05-10 | 2024-05-31 | 227717 |
| APO-SITAGLIPTIN MALATE | 25MG | TABLET | Resolved | 2024-04-12 | 2024-05-31 | 224977 |
| APO-SITAGLIPTIN MALATE | 50MG | TABLET | Resolved | 2024-04-12 | 2024-05-31 | 224996 |
| APO-TADALAFIL | 2.5MG | TABLET | Resolved | 2024-04-19 | 2024-05-31 | 225773 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-QUININE | 300MG | CAPSULE | Discontinued | 2018-09-08 | 2021-05-10 | 60714 |
| APO-METOPROLOL | 25MG | TABLET | To be discontinued | 2018-09-07 | 2021-06-03 | 60628 |
| APO-AMITRIPTYLINE | 50MG | TABLET | To be discontinued | 2019-01-04 | 2021-06-05 | 71354 |
| APO-QUETIAPINE | 25MG | TABLET | Discontinued | 2021-06-25 | 2021-06-25 | 141546 |
| APO-PINDOL TAB 5MG | 5MG | TABLET | Discontinued | 2022-02-09 | 2022-02-10 | 154568 |
| APO-PINDOL TAB 10MG | 10MG | TABLET | Discontinued | 2022-02-09 | 2022-02-10 | 154571 |
| MELPHALAN FOR INJECTION | 10ML 50MG | POWDER FOR SOLUTION KIT SOLUTION | Discontinued | 2022-03-23 | 2022-03-23 | 157136 |
| APO-BICALUTAMIDE | 50MG | TABLET | Discontinued | 2022-03-25 | 2022-05-13 | 157376 |
| APO-CLOBETASOL SPRAY | 0.05% | SPRAY | Discontinued | 2022-09-06 | 2022-09-06 | 168648 |
| APO-PINDOL TAB 15MG | 15MG | TABLET | Discontinued | 2022-02-09 | 2022-12-09 | 154574 |
| APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE | 300MG 150MG 300MG | TABLET | Discontinued | 2022-12-12 | 2022-12-12 | 177953 |
| APO-VALPROIC ACID ORAL SOLUTION | 250MG | SOLUTION | Discontinued | 2023-09-26 | 2023-11-02 | 205310 |
| APO-CARVEDILOL | 6.25MG | TABLET | To be discontinued | 2024-01-26 | 2024-01-26 | 217499 |
| APO-CARVEDILOL | 3.125MG | TABLET | To be discontinued | 2024-01-26 | 2024-01-26 | 217496 |
| APO-CARVEDILOL | 25MG | TABLET | Discontinued | 2024-01-26 | 2024-01-27 | 217504 |
| APO-CARVEDILOL | 12.5MG | TABLET | To be discontinued | 2024-01-26 | 2024-04-01 | 217493 |